Loading…

Progressive Global Ataxia With Sensory Changes as a Paraneoplastic Syndrome in a Patient With Chromophobe Renal Cell Carcinoma

Paraneoplastic syndromes (PNS) are rare and can be challenging to diagnose and treat. The uniqueness of PNS lies in the complexity of presentation, the importance of early diagnosis, and the role of multidisciplinary care in managing those patients to mitigate long-term neurologic complications. We...

Full description

Saved in:
Bibliographic Details
Published in:Curēus (Palo Alto, CA) CA), 2022-05, Vol.14 (5), p.e24913
Main Authors: Basree, Mustafa M, Rudy, Raquel, Romaniello, Cristina, Smith, Daniel E, Kander, Elizabeth
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c266t-438890be27cabd846d52f814918adafa7f9739bb23a68a36d549c921425345543
container_end_page
container_issue 5
container_start_page e24913
container_title Curēus (Palo Alto, CA)
container_volume 14
creator Basree, Mustafa M
Rudy, Raquel
Romaniello, Cristina
Smith, Daniel E
Kander, Elizabeth
description Paraneoplastic syndromes (PNS) are rare and can be challenging to diagnose and treat. The uniqueness of PNS lies in the complexity of presentation, the importance of early diagnosis, and the role of multidisciplinary care in managing those patients to mitigate long-term neurologic complications. We describe a patient with metastatic renal cell carcinoma who presented with a complex constellation of neurological symptoms (progressive global ataxia and sensory changes) that did not resolve following nephrectomy. While complete resolution of symptoms was not achieved, he did have stabilization of his neurologic decline with the initiation of cancer-directed therapies.
doi_str_mv 10.7759/cureus.24913
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9187143</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2682639240</sourcerecordid><originalsourceid>FETCH-LOGICAL-c266t-438890be27cabd846d52f814918adafa7f9739bb23a68a36d549c921425345543</originalsourceid><addsrcrecordid>eNpVUd9LHDEQDqXiifrmcwn0tXfm126Sl4Isei0Iilr6GGZ3s7eRveSa7Ir30r-90buKwjAz8H3zzQwfQmeULKQs9HkzRTulBROa8k_oiNFSzRVV4vO7foZOU3okhFAiGZHkEM14UWolKTtCf29jWEWbknuyeDmEGgZ8McKzA_zbjT2-tz6FuMVVD35lE4Yc-BYieBs2A6TRNfh-69sY1hY7_wqOzvpxN171GQibPtQW31mfxSs75ASxcT6s4QQddDAke7qvx-jX1eVD9WN-fbP8WV1czxtWluNccKU0qS2TDdStEmVbsE7R_LWCFjqQnZZc1zXjUCrgGRa60YwKVnBRFIIfo-873c1Ur23b5AMjDGYT3Rri1gRw5iPiXW9W4cnkDZIKngW-7gVi-DPZNJrHMMX8UDKsVKzkmgmSWd92rCaGlKLt3jZQYl4MMzvDzKthmf7l_VVv5P_28H9uYZPQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2682639240</pqid></control><display><type>article</type><title>Progressive Global Ataxia With Sensory Changes as a Paraneoplastic Syndrome in a Patient With Chromophobe Renal Cell Carcinoma</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>PubMed Central</source><source>Coronavirus Research Database</source><creator>Basree, Mustafa M ; Rudy, Raquel ; Romaniello, Cristina ; Smith, Daniel E ; Kander, Elizabeth</creator><creatorcontrib>Basree, Mustafa M ; Rudy, Raquel ; Romaniello, Cristina ; Smith, Daniel E ; Kander, Elizabeth</creatorcontrib><description>Paraneoplastic syndromes (PNS) are rare and can be challenging to diagnose and treat. The uniqueness of PNS lies in the complexity of presentation, the importance of early diagnosis, and the role of multidisciplinary care in managing those patients to mitigate long-term neurologic complications. We describe a patient with metastatic renal cell carcinoma who presented with a complex constellation of neurological symptoms (progressive global ataxia and sensory changes) that did not resolve following nephrectomy. While complete resolution of symptoms was not achieved, he did have stabilization of his neurologic decline with the initiation of cancer-directed therapies.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.24913</identifier><identifier>PMID: 35698712</identifier><language>eng</language><publisher>United States: Cureus Inc</publisher><subject>Amyotrophic lateral sclerosis ; Antibodies ; Ataxia ; Autoimmune diseases ; Case reports ; Coronaviruses ; COVID-19 vaccines ; Diplopia ; Electromyography ; Guillain-Barre syndrome ; Hypercalcemia ; Internal Medicine ; Kidney cancer ; Lymphatic system ; Magnetic resonance imaging ; Metastasis ; Motor neurone disease ; Nervous system ; Neurology ; Occupational therapy ; Oncology ; Patients ; Peripheral neuropathy ; Tumors ; Urinary retention</subject><ispartof>Curēus (Palo Alto, CA), 2022-05, Vol.14 (5), p.e24913</ispartof><rights>Copyright © 2022, Basree et al.</rights><rights>Copyright © 2022, Basree et al. This work is published under https://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2022, Basree et al. 2022 Basree et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c266t-438890be27cabd846d52f814918adafa7f9739bb23a68a36d549c921425345543</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2682639240/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2682639240?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,38516,43895,44590,53791,53793,74412,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35698712$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Basree, Mustafa M</creatorcontrib><creatorcontrib>Rudy, Raquel</creatorcontrib><creatorcontrib>Romaniello, Cristina</creatorcontrib><creatorcontrib>Smith, Daniel E</creatorcontrib><creatorcontrib>Kander, Elizabeth</creatorcontrib><title>Progressive Global Ataxia With Sensory Changes as a Paraneoplastic Syndrome in a Patient With Chromophobe Renal Cell Carcinoma</title><title>Curēus (Palo Alto, CA)</title><addtitle>Cureus</addtitle><description>Paraneoplastic syndromes (PNS) are rare and can be challenging to diagnose and treat. The uniqueness of PNS lies in the complexity of presentation, the importance of early diagnosis, and the role of multidisciplinary care in managing those patients to mitigate long-term neurologic complications. We describe a patient with metastatic renal cell carcinoma who presented with a complex constellation of neurological symptoms (progressive global ataxia and sensory changes) that did not resolve following nephrectomy. While complete resolution of symptoms was not achieved, he did have stabilization of his neurologic decline with the initiation of cancer-directed therapies.</description><subject>Amyotrophic lateral sclerosis</subject><subject>Antibodies</subject><subject>Ataxia</subject><subject>Autoimmune diseases</subject><subject>Case reports</subject><subject>Coronaviruses</subject><subject>COVID-19 vaccines</subject><subject>Diplopia</subject><subject>Electromyography</subject><subject>Guillain-Barre syndrome</subject><subject>Hypercalcemia</subject><subject>Internal Medicine</subject><subject>Kidney cancer</subject><subject>Lymphatic system</subject><subject>Magnetic resonance imaging</subject><subject>Metastasis</subject><subject>Motor neurone disease</subject><subject>Nervous system</subject><subject>Neurology</subject><subject>Occupational therapy</subject><subject>Oncology</subject><subject>Patients</subject><subject>Peripheral neuropathy</subject><subject>Tumors</subject><subject>Urinary retention</subject><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><recordid>eNpVUd9LHDEQDqXiifrmcwn0tXfm126Sl4Isei0Iilr6GGZ3s7eRveSa7Ir30r-90buKwjAz8H3zzQwfQmeULKQs9HkzRTulBROa8k_oiNFSzRVV4vO7foZOU3okhFAiGZHkEM14UWolKTtCf29jWEWbknuyeDmEGgZ8McKzA_zbjT2-tz6FuMVVD35lE4Yc-BYieBs2A6TRNfh-69sY1hY7_wqOzvpxN171GQibPtQW31mfxSs75ASxcT6s4QQddDAke7qvx-jX1eVD9WN-fbP8WV1czxtWluNccKU0qS2TDdStEmVbsE7R_LWCFjqQnZZc1zXjUCrgGRa60YwKVnBRFIIfo-873c1Ur23b5AMjDGYT3Rri1gRw5iPiXW9W4cnkDZIKngW-7gVi-DPZNJrHMMX8UDKsVKzkmgmSWd92rCaGlKLt3jZQYl4MMzvDzKthmf7l_VVv5P_28H9uYZPQ</recordid><startdate>20220511</startdate><enddate>20220511</enddate><creator>Basree, Mustafa M</creator><creator>Rudy, Raquel</creator><creator>Romaniello, Cristina</creator><creator>Smith, Daniel E</creator><creator>Kander, Elizabeth</creator><general>Cureus Inc</general><general>Cureus</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>20220511</creationdate><title>Progressive Global Ataxia With Sensory Changes as a Paraneoplastic Syndrome in a Patient With Chromophobe Renal Cell Carcinoma</title><author>Basree, Mustafa M ; Rudy, Raquel ; Romaniello, Cristina ; Smith, Daniel E ; Kander, Elizabeth</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c266t-438890be27cabd846d52f814918adafa7f9739bb23a68a36d549c921425345543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Amyotrophic lateral sclerosis</topic><topic>Antibodies</topic><topic>Ataxia</topic><topic>Autoimmune diseases</topic><topic>Case reports</topic><topic>Coronaviruses</topic><topic>COVID-19 vaccines</topic><topic>Diplopia</topic><topic>Electromyography</topic><topic>Guillain-Barre syndrome</topic><topic>Hypercalcemia</topic><topic>Internal Medicine</topic><topic>Kidney cancer</topic><topic>Lymphatic system</topic><topic>Magnetic resonance imaging</topic><topic>Metastasis</topic><topic>Motor neurone disease</topic><topic>Nervous system</topic><topic>Neurology</topic><topic>Occupational therapy</topic><topic>Oncology</topic><topic>Patients</topic><topic>Peripheral neuropathy</topic><topic>Tumors</topic><topic>Urinary retention</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Basree, Mustafa M</creatorcontrib><creatorcontrib>Rudy, Raquel</creatorcontrib><creatorcontrib>Romaniello, Cristina</creatorcontrib><creatorcontrib>Smith, Daniel E</creatorcontrib><creatorcontrib>Kander, Elizabeth</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest - Health &amp; Medical Complete保健、医学与药学数据库</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Curēus (Palo Alto, CA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Basree, Mustafa M</au><au>Rudy, Raquel</au><au>Romaniello, Cristina</au><au>Smith, Daniel E</au><au>Kander, Elizabeth</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Progressive Global Ataxia With Sensory Changes as a Paraneoplastic Syndrome in a Patient With Chromophobe Renal Cell Carcinoma</atitle><jtitle>Curēus (Palo Alto, CA)</jtitle><addtitle>Cureus</addtitle><date>2022-05-11</date><risdate>2022</risdate><volume>14</volume><issue>5</issue><spage>e24913</spage><pages>e24913-</pages><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>Paraneoplastic syndromes (PNS) are rare and can be challenging to diagnose and treat. The uniqueness of PNS lies in the complexity of presentation, the importance of early diagnosis, and the role of multidisciplinary care in managing those patients to mitigate long-term neurologic complications. We describe a patient with metastatic renal cell carcinoma who presented with a complex constellation of neurological symptoms (progressive global ataxia and sensory changes) that did not resolve following nephrectomy. While complete resolution of symptoms was not achieved, he did have stabilization of his neurologic decline with the initiation of cancer-directed therapies.</abstract><cop>United States</cop><pub>Cureus Inc</pub><pmid>35698712</pmid><doi>10.7759/cureus.24913</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2168-8184
ispartof Curēus (Palo Alto, CA), 2022-05, Vol.14 (5), p.e24913
issn 2168-8184
2168-8184
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9187143
source Publicly Available Content Database (Proquest) (PQ_SDU_P3); PubMed Central; Coronavirus Research Database
subjects Amyotrophic lateral sclerosis
Antibodies
Ataxia
Autoimmune diseases
Case reports
Coronaviruses
COVID-19 vaccines
Diplopia
Electromyography
Guillain-Barre syndrome
Hypercalcemia
Internal Medicine
Kidney cancer
Lymphatic system
Magnetic resonance imaging
Metastasis
Motor neurone disease
Nervous system
Neurology
Occupational therapy
Oncology
Patients
Peripheral neuropathy
Tumors
Urinary retention
title Progressive Global Ataxia With Sensory Changes as a Paraneoplastic Syndrome in a Patient With Chromophobe Renal Cell Carcinoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T11%3A03%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Progressive%20Global%20Ataxia%20With%20Sensory%20Changes%20as%20a%20Paraneoplastic%20Syndrome%20in%20a%20Patient%20With%20Chromophobe%20Renal%20Cell%20Carcinoma&rft.jtitle=Cur%C4%93us%20(Palo%20Alto,%20CA)&rft.au=Basree,%20Mustafa%20M&rft.date=2022-05-11&rft.volume=14&rft.issue=5&rft.spage=e24913&rft.pages=e24913-&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.24913&rft_dat=%3Cproquest_pubme%3E2682639240%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c266t-438890be27cabd846d52f814918adafa7f9739bb23a68a36d549c921425345543%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2682639240&rft_id=info:pmid/35698712&rfr_iscdi=true